Novavax Stock (NASDAQ: NVAX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 37.763K / 14.306M |
Day Range | - - - |
52 Wk Range | 3.532 - 23.860 |
Market Cap | $2.379B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 57 |
Short Interest | 33.07% |
Days to Cover | 2.3 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Novavax (NASDAQ:NVAX) through any online brokerage.
Other companies in Novavax’s space includes: MoonLake (NASDAQ:MLTX), TG Therapeutics (NASDAQ:TGTX), Protagonist Therapeutics (NASDAQ:PTGX), Agios Pharmaceuticals (NASDAQ:AGIO) and Apogee Therapeutics (NASDAQ:APGE).
There is no analysis for Novavax
The stock price for Novavax (NASDAQ: NVAX) is $16.15 last updated Today at June 13, 2024 at 7:00 AM EDT.
There are no upcoming dividends for Novavax.
Novavax’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Novavax.
Novavax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.